G. Johnsson

发表

C. Regårdh, B. Edgar, G. Johnsson, 1985, Clinical pharmacology and therapeutics.

Comparable Pharmacokinetics and Pharmacodynamics of Melagatran in Japanese and Caucasian Volunteers after Oral Administration of the Direct Thrombin Inhibitor Ximelagatran

G. Johnsson, U. Eriksson, A. Bylock, 2006, Clinical pharmacokinetics.

The interaction effect of grapefruit juice is maximal after the first glass

C. Regårdh, B. Edgar, G. Johnsson, 1998, European Journal of Clinical Pharmacology.

Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics on felodipine — and its potential clinical relevance

R. Bergstrand, C. Regårdh, B. Edgar, 2004, European Journal of Clinical Pharmacology.

Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long‐term treatment

C. Regårdh, G. Johnsson, C. Bengtsson, 1975, Clinical pharmacology and therapeutics.

Withdrawal Symptoms in Workers Exposed to Nitroglycerine

G. Johnsson, J. Häggendal, R. Lund, 1968, British journal of industrial medicine.

Effects on haemodynamics and plasma noradrenaline levels in man of long term treatment with imipramine, haloperidol and chlorpromazine

G. Grimby, G. Johnsson, J. Häggendal, 1971, European Journal of Clinical Pharmacology.

Effects of adrenaline and alprenolol (Aptin®) on blood coagulation and fibrinolysis in man

G. Johnsson, J. Kral, K. Korsan-Bengtsen, 1971, European Journal of Clinical Pharmacology.

Hemodynamic effects of propranolol and H 56/28 in man. A comparative study of two beta-adrenergic receptor antagonists.

G. Johnsson, S. Forsberg, 1967, Life sciences.

Interference of phenoxybenzamine and guanethidine with the vasoconstrictor responses of noradrenaline and angiotensin II in the hand.

G. Johnsson, M. Henning, 2009, Acta pharmacologica et toxicologica.

The effects of hydralazine administered into the brachial artery on adrenergic vasoconstrictor stimuli in the hand.

G. Johnsson, B. Åblad, M. Henning, 2009, Acta pharmacologica et toxicologica.

Plasma Concentrations and Beta‐Blocking Effects in Normal Volunteers After Intravenous Doses of Metoprolol and Propranolol

C. Regårdh, G. Johnsson, O. Rönn, 1980, Journal of cardiovascular pharmacology.

Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.

C. Regårdh, G. Johnsson, L. Sölvell, 2009, Acta pharmacologica et toxicologica.

Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work.

G. Johnsson, 2009, Acta pharmacologica et toxicologica.

Effects of cedilanid-D in combination with metoprolol on exercise tolerance and systolic time intervals in angina pectoris.

G. Johnsson, L. Ekelund, A. Melcher, 1976, The American journal of cardiology.

COMPARATIVE EFFECTS OF INTRA-ARTERIALLY ADMINISTERED HYDRALAZINE AND SODIUM NITRITE ON BLOOD FLOW AND VOLUME OF FOREARM.

G. Johnsson, B. Åblad, 1963, Acta pharmacologica et toxicologica.

Effects of cedilanid-D and alprenolol in angina pectoris

G. Johnsson, L. Ekelund, A. Melcher, 1973, European Journal of Clinical Pharmacology.

Potency and time-effect relationship in man of propranolol and H 56-28--comparative studies after oral administration.

G. Johnsson, B. Åblad, A. Norrby, 2009, Acta pharmacologica et toxicologica.

Potency and time effect relationship in man of propranolol and H 56-28. I. Comparative studies after intravenous administration. II. Studies on the ratio of equipotent oral and intravenous doses.

G. Johnsson, A. Norrby, L. Sölvell, 2009, Acta pharmacologica et toxicologica.

Metabolic and cardiovascular effects of adrenaline and alprenolol (Aptin®) in human subjects

P. Björntorp, G. Johnsson, J. Kral, 1969, Pharmacologia Clinica.

Mode of Action of Beta Blockers in Angina Pectoris

G. Johnsson, B. Åblad, E. Carlsson, 1977, Scottish medical journal.

Effects of metoprolol and propranolol on some metabolic responses to catecholamines in the anaesthetized dog.

G. Johnsson, B. Åblad, E. Carlsson, 2009, Acta pharmacologica et toxicologica.

Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.

C. Regårdh, G. Johnsson, B. Åblad, 1974, Life sciences.

Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man.

G. Johnsson, J. Stenberg, R. Sannerstedt, 1971, The American journal of cardiology.

Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate.

G. Johnsson, C. Bengtsson, R. Sannerstedt, 1975, British medical journal.

Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, in man

G. Johnsson, P. Lundborg, O. Rönn, 1980, European Journal of Clinical Pharmacology.

Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

C. Regårdh, G. Johnsson, 1976, Clinical pharmacokinetics.

Hemodynamic Effects of Propranolol 1 and H 56/28 2 in Man—a Comparative Study of two β‐adrenergic Receptor Antagonists

G. Johnsson, S. Forsberg, 2009 .

Interaction in Healthy Volunteers Between Prenalterol, A Selective β1‐Adrenoceptor Agonist, and Metoprolol or Propranolol

G. Johnsson, P. Lundborg, O. Rönn, 1981, Journal of cardiovascular pharmacology.

Pharmacokinetics of procainamide intravenously and orally as conventional and slow‐release tablets

J. Sjögren, G. Johnsson, C. Graffner, 1975, Clinical pharmacology and therapeutics.

Haemodynamic and tolerance studies in man of a new, orally active, selectiveβ1-adrenoceptor agonist H 80/62

G. Johnsson, P. Lundborg, O. Rönn, 1978, European Journal of Clinical Pharmacology.

Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.

G. Johnsson, P. Lundborg, O. Rönn, 1979, British journal of clinical pharmacology.

Clinical Pharmacokinetics of β-Adrenoceptor Blocking Drugs

C. Regårdh, G. Johnsson, 1976 .

Alteration of metastases distribution by vaso-dilating drugs.

G. Johnsson, W. Ryd, B. Boeryd, 1975, Pathologia Europaea.

Studies on the mechanism of the vasoconstrictor effect of angiotensin II in man.

G. Johnsson, B. Åblad, M. Henning, 1965, Life sciences.

Interference of intra-arterially administred phenoxybenzamine, guanethidine and hydralazine with the adrenergic vasoconstrictor function in the hand: a comparative study in man.

G. Johnsson, M. Henning, 2009, Acta pharmacologica et toxicologica.

Effects of single doses of alprenolol and two cardioselective β-blockers (H 87/07 and H 93/26) on exercise-induced angina pectoris

C. Furberg, G. Johnsson, L. Adolfsson, 2004, European Journal of Clinical Pharmacology.

Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man

G. Johnsson, P. Lundborg, O. Rönn, 1979, European Journal of Clinical Pharmacology.

Clinical Pharmacokinetics of Metoprolol

C. Regårdh, G. Johnsson, C G Regårdh, 1980, Clinical pharmacokinetics.

Pharmacokinetic studies in man of the selective beta1-adrenoceptor agonist, prenalterol

G. Johnsson, P. Lundborg, O. Rönn, 2004, European Journal of Clinical Pharmacology.

Pharmacodynamic effects of prenalterol in healthy subjects.

G. Johnsson, 2009, Acta medica Scandinavica. Supplementum.

Interindividual variations in metoprolol metabolism--some clinical and other observations.

C. Regårdh, G. Johnsson, 1984, British journal of clinical pharmacology.

Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men

C. Regårdh, B. Edgar, G. Johnsson, 1997, European Journal of Clinical Pharmacology.

Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.

C. Regårdh, G. Johnsson, L. Sölvell, 2009, Acta pharmacologica et toxicologica.

Pharmacokinetic and Pharmacodynamic Properties of Metoprolol in Patients with Impaired Renal Function

C. Regårdh, G. Johnsson, L. Johansson, 1980, Clinical pharmacokinetics.

Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics

G. Johnsson, N. Svedmyr, G. Johnsson, 1975, European Journal of Clinical Pharmacology.

Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline.

G. Nyberg, G. Johnsson, L. Sölvell, 2009, Acta pharmacologica et toxicologica.

Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects

C. Regårdh, B. Edgar, G. Johnsson, 2004, European Journal of Clinical Pharmacology.

Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.

C. Regårdh, G. Johnsson, P. Lundborg, 1980, International journal of clinical pharmacology, therapy, and toxicology.

Pharmacokinetics of felodipine in patients with impaired renal function.

C. Regårdh, B. Edgar, G. Johnsson, 1989, British journal of clinical pharmacology.

Pharmacological effects and serum levels of orally administered alprenolol in man

G. Johnsson, M. Ervik, B. Åblad, 1972, European Journal of Clinical Pharmacology.

Alprenolol in hypertension.

G. Johnsson, 2009, Acta medica Scandinavica. Supplementum.

The haemodynamic effects of alprenolol and propranolol at rest and during exercise in hypertensive patients

G. Johnsson, R. Sannerstedt, H. Bergman, 1969, Pharmacologia Clinica.

Comparative absorption and pharmacokinetic studies on proxyphylline in ordinary and slow release tablets.

J. Sjögren, G. Johnsson, C. Graffner, 1974, Acta pharmaceutica Suecica.

Pharmacokinetic studies on proxyphylline administered intravenously and orally to man.

J. Sjögren, G. Johnsson, C. Graffner, 1973, Acta pharmaceutica Suecica.

Pharmacokinetic studies on the selectiveβ1-receptor antagonist metoprolol in man

R. Johansson, C. Regårdh, G. Johnsson, 1974, Journal of Pharmacokinetics and Biopharmaceutics.

Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects

G. Johnsson, I. Hutton, A. Tweddel, 2004, European Journal of Clinical Pharmacology.

Comparative effects of isoprenaline and nitroglycerin on consecutive vascular sections in the skeletal muscle of the cat.

G. Johnsson, B. Oberg, 1968, Angiologica.

Comparative effects of intra-arterially administered isoprenaline and sodium nitrite on blood flow and volume of the forearm.

G. Johnsson, 2009, Acta pharmacologica et toxicologica.

Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise.

G. Grimby, G. Johnsson, J. Häggendal, 1976, International journal of clinical pharmacology and biopharmacy.

The systemic and coronary haemodynamic effects of felodipine in patients with coronary heart disease.

G. Johnsson, T. Pringle, I. Hutton, 1983, European heart journal.

The plasma content and excretion of catecholamines in nitroglycerine workers.

G. Johnsson, J. Häggendal, R. Lund, 1968, British journal of industrial medicine.

Rate of onset of vasodilator effect of glyceryl trinitrate, propatylnitrate and erythrityl tetranitrate in man.

G. Johnsson, B. Åblad, M. Henning, 1965, Scandinavian journal of clinical and laboratory investigation.

Effects of EACA, AMCHA and guanethidine on metastases induced by intravenously injected tumour cells.

G. Johnsson, W. Ryd, B. Boeryd, 1974, Pathologia Europaea.

Lack of biological interaction of alprenolol and salicylate in man

C. Regårdh, G. Johnsson, L. Sölvell, 1973, European Journal of Clinical Pharmacology.

A dose-response study on metoprolol in angina pectoris.

G. Johnsson, O. Keyriläinen, A. Uusitalo, 1981, Annals of clinical research.

Clinical Pharmacokinetics ofβ-Adrenoreceptor Blockers

C. Regårdh, G. Johnsson, 2012, Drugs.

Pharmacokinetics of lidocaine in healthy individuals pretreated with multiple doses of metoprolol.

C. Regårdh, G. Johnsson, P. Lundborg, 1984, International journal of clinical pharmacology, therapy, and toxicology.

BIOAVAILABILITY OF β‐ADRENOCEPTOR BLOCKING DRUGS

C. Regårdh, G. Johnsson, 1976 .

Hemodynamic effects of propranolol and H 56-28 in man--comparative study of two beta-adrenergic receptor antagonists.

G. Johnsson, S. Forsberg, 1967, Acta pharmacologica et toxicologica.

The effects of intra-arterially administered propranolol and H 56-28 on blood flow in the forearm--a comparative study of two beta-adrenergic receptor antagonists.

G. Johnsson, 2009, Acta pharmacologica et toxicologica.

Beta-blocking effect and serum levels of alprenolol in man after administration of ordinary and sustained release tablets

J. Sjögren, G. Johnsson, L. Sölvell, 1971, European Journal of Clinical Pharmacology.

Effects of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects

G. Johnsson, P. Attman, M. Aurell, 1975, European Journal of Clinical Pharmacology.